LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,141,412 | -5.8% | 865,586 | -3.2% | 0.00% | 0.0% |
| Q2 2023 | $61,751,132 | +36.3% | 894,555 | -4.8% | 0.00% | 0.0% |
| Q1 2023 | $45,300,279 | -43.3% | 939,450 | -41.3% | 0.00% | +50.0% |
| Q4 2022 | $79,909,240 | +155.7% | 1,600,746 | +109.0% | 0.00% | 0.0% |
| Q3 2022 | $31,246,000 | -19.7% | 765,825 | +8.2% | 0.00% | 0.0% |
| Q2 2022 | $38,928,000 | +57.0% | 707,783 | +3.7% | 0.00% | +100.0% |
| Q1 2022 | $24,796,000 | -18.8% | 682,346 | +4.1% | 0.00% | 0.0% |
| Q4 2021 | $30,537,000 | +438.6% | 655,168 | +484.2% | 0.00% | – |
| Q3 2021 | $5,670,000 | +27.9% | 112,142 | +3.9% | 0.00% | – |
| Q2 2021 | $4,432,000 | +68.2% | 107,963 | +18.9% | 0.00% | – |
| Q1 2021 | $2,635,000 | +13.9% | 90,811 | +10.5% | 0.00% | – |
| Q4 2020 | $2,314,000 | – | 82,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |